According to the Centers for Disease Control and Prevention (CDC), over 105,000 Americans died from a drug overdose in 2023, with approximately 79,000 of those deaths involving an opioid.
It’s encouraging that preliminary 2024 data shows a significant decline, with overdose deaths dropping nearly 27% to around 80,000, which is the lowest level since 2019. Fentanyl and other synthetic opioids remain the primary driver, accounting for roughly 69% of all overdose deaths.
While current therapies, including medications for opioid use disorder (MOUD) such as methadone, buprenorphine, and naltrexone, have proven helpful in preventing overdose deaths, relapse remains a serious challenge. Research suggests relapse rates can reach as high as 90% within the first year of treatment.
Researchers at Columbia University Vagelos College of Physicians and Surgeons in New York are currently testing an experimental vaccine for the treatment of opioid use disorder.
Here you’ll find information on:
- how the experimental opioid vaccine works
- when the vaccine will be available if approved
- why you might choose the opioid vaccine over other treatment options
- the potential side effects of the vaccine
- other therapies used to treat opioid use disorder
How Will The Opioid Vaccine Work?
Vaccines are an important weapon for public health in the fight against various diseases. Recent research shows that preventative vaccines may also be able to treat people with pre-existing health conditions, including substance use disorders.
All vaccines work similarly: through teaching the body’s immune system to create antibodies that can recognize and destroy antigens, like the poliovirus or the seasonal flu.
An opioid vaccine would be designed to teach the body to recognize an opioid molecule in the body, and the resulting immune response would prevent the opioids from entering the brain.
Opioid molecules can typically cross the blood-brain barrier because they are very small, but an opioid molecule stuck to an antibody would be too big to get through. This would result in there being no pleasure response from using opioids.
Because fentanyl and other synthetic opioids now account for approximately 69% of all overdose deaths in the U.S., researchers are prioritizing the development of a fentanyl-specific vaccine alongside oxycodone and heroin candidates.
When Will The Opioid Vaccine Be Available?
Dr. Sandra Comer, professor and director of the Opioid Laboratory at Columbia University Vagelos College of Physicians and Surgeons, and Dr. Marco Pravetoni, professor at the University of Washington School of Medicine, have led the oxycodone vaccine research into human clinical trials.
The Phase 1a/1b oxycodone vaccine trial has enrolled volunteers who are closely monitored during an inpatient stay to assess their response to oxycodone after vaccination. Separately, Phase 1 trials for heroin and fentanyl vaccines began in 2024, also based at Columbia, and are supported by the NIH HEAL (Helping to End Addiction Long-Term) initiative.
As of 2026, only a small number of opioid vaccine clinical trials have been completed and published, and the FDA hasn’t approved an opioid vaccine. Researchers still need to complete Phase 2 and Phase 3 trials before any vaccine could be available to the public.
Why Choose The Opioid Vaccine Over Other Treatments?
If the opioid vaccine is available for public use, it would likely be combined with other medications used for opioid use disorder, as it would not interfere with prescription medications such as naltrexone.
You would not necessarily have to choose between the vaccine or traditional treatment, but use it as a supplement to ensure a better chance at long-term recovery.
What Are The Potential Side Effects And Risks?
The side effects of an opioid vaccine are not fully known, but there are concerns among experts about the risk of denying adequate pain control for people vaccinated against oxycodone.
For example, if a person were in a car accident, they may not be responsive to high doses of prescription opioids used to treat their pain due to their opioid vaccine.
This issue could be mitigated through the use of other pain management methods, but this could also prove troublesome as people could simply use other substances not protected by the vaccine.
Other Options For Opioid Use Disorder Treatment
Currently, there are several approved methods for treating opioid use disorder. These evidence-based approaches to care have been proven over time to promote the best outcomes for people who need help.
Treatment options for an opioid addiction may include:
- buprenorphine, methadone, or naltrexone maintenance
- dual diagnosis care for co-occurring mental health and substance use disorders
- crisis interventions
- medical detoxification
- behavioral therapies
- family, group, and individual counseling
Until an opioid vaccine becomes available, the treatment options above offer the best-supported path toward long-term recovery from opioid use disorder.
Recover From Substance Use Disorder
The opioid epidemic has been ongoing, but help is available for you or your loved one. Several inpatient and outpatient treatments for opioid use have proven effective.
For additional information about opioid use disorder treatment, contact our helpline today. Our team may also assist you in finding a treatment program or detox clinic in your area.
Addiction Resource aims to provide only the most current, accurate information in regards to addiction and addiction treatment, which means we only reference the most credible sources available.
These include peer-reviewed journals, government entities and academic institutions, and leaders in addiction healthcare and advocacy. Learn more about how we safeguard our content by viewing our editorial policy.
- CBS News — An Experimental Vaccine Could Help Fight the Opioid Epidemic
https://www.cbsnews.com/news/opioid-epidemic-experimental-vaccine-oxycodone/ - Columbia University Irving Medical Center — Experimental Opioid Vaccine Being Tested at Columbia
https://www.cuimc.columbia.edu/news/experimental-opioid-vaccine-being-tested-columbia - National Institutes of Health (NIH) — A Shot Against Opioids
https://heal.nih.gov/news/stories/OUD-vaccine - University of Minnesota Medical School — First-in-human clinical trial for a vaccine to treat opioid use disorders enrolls first patients
https://med.umn.edu/news/first-human-clinical-trial-vaccine-treat-opioid-use-disorders-enrolls-first-patients
